Patient Advocacy Advancing Breakthrough Science and Community Engagement

09/16/24 • 28 min

Join Desiree Underwood-Williams, director of project management organization at WCG and guest Steve Smith, CEO of SteveSmithPlans LLC and facilitator of the WCG Patient Forum, as they recap the latest Patient Forum Focus Session on breakthrough science and community engagement. Discussion highlights include:

The impact of medical diagnoses on families with Sickle cell disease and melanoma.
New research in cell and gene therapy that’s directly impacting Sickle cell disease and melanoma patients.
New diversity laws shaping the future of drug development.
Community engagement and how patients can get involved in their care.
And more insights into the WCG Patient Forum, now in its fifth year.

Tune in to learn more about clinical research, community engagement, and the latest developments in patient care.

The impact of medical diagnoses on families with Sickle cell disease and melanoma.
New research in cell and gene therapy that’s directly impacting Sickle cell disease and melanoma patients.
New diversity laws shaping the future of drug development.
Community engagement and how patients can get involved in their care.
And more insights into the WCG Patient Forum, now in its fifth year.

Tune in to learn more about clinical research, community engagement, and the latest developments in patient care.

Previous Episode

Guarding Research Integrity: The IRB's Essential Role

In this episode of WCG Talks Trials, we are joined by host Joanne Thomas, clinical reviewer and patient advocate at WCG, along with our guest Currien MacDonald, medical chair director at WCG. This episode covers the roles of IRB in ethical clinical research, frequently asked questions, and a general overview of the IRB’s role in clinical trials.

Next Episode

Breaking Barriers: Reasons to Expand Site Cancer Trial Portfolios

In this episode of WCG Talks Trials, Geoff Schick, director of strategic site partnerships, joins our host Sandy Smith, senior vice president of clinical solutions and strategic partnering, to discuss the expansion of research site cancer portfolios.